Introduction
Sermorelin is a synthetic 29-amino-acid peptide analog corresponding to the N-terminal fragment (residues 1-29) of growth hormone-releasing hormone (GHRH), amidated at the C-terminus. In laboratory research it is used as a defined GHRH-receptor agonist tool compound for studying GH-axis signaling in cell-based systems.
For laboratory research use only. Not for human or veterinary use or consumption.
Molecular Structure
The full-length GHRH peptide is 44 amino acids; structure-activity studies established that the 1-29 fragment retains receptor-binding activity, and C-terminal amidation improves stability in laboratory preparations. Sermorelin’s defined sequence makes it amenable to standard solid-phase synthesis and rigorous analytical characterization.
Cell Culture Study Design
In the literature, GHRH analogs are studied in pituitary-derived cell culture models (such as GH-secreting cell lines and primary pituitary cultures) to characterize receptor binding, second-messenger signaling (cAMP assays), and downstream transcriptional responses. Radioligand and fluorescence-based binding assays are standard readouts, alongside reporter-gene systems for pathway activation. These models allow precise control of exposure conditions and are the standard pre-analytical setting for receptor pharmacology work.
Analytical Characterization
Identity and purity are confirmed by reversed-phase HPLC and mass spectrometry, with amino acid analysis used to verify composition. Because even minor synthesis byproducts (deletion sequences, oxidation products) can alter receptor-assay results, COA documentation of chromatographic purity and mass confirmation is essential before a lot is used in sensitive cell-based assays.
Storage and Handling
Lyophilized material is stored at -20 C or below in desiccated, light-protected conditions. Aliquoting practices that minimize freeze-thaw exposure follow standard peptide laboratory protocols.
References
- Guillemin R, Brazeau P, Bohlen P, et al. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science. 1982;218(4572):585-587.
- Thorner MO, Vance ML, Horvath E, Kovacs K. The pituitary somatotroph adenoma and growth hormone-releasing hormone. Pathol Res Pract. 1991;187(5):513-517.